Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2005-07-19
2005-07-19
Nickol, G. (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C514S002600
Reexamination Certificate
active
06919425
ABSTRACT:
The present invention provides a tumor-homing peptide that can target cancer and or tumor tissues. The peptide is uptaken by certain specific cancer cell types. The invention describes methods to achieve targeted delivery of anticancer drugs conjugated to this peptide for anticancer therapy. The invention also describes methods for using the peptide for the diagnosis and imaging of cancer and tumor tissues.
REFERENCES:
patent: 5087616 (1992-02-01), Myers et al.
patent: 6303576 (2001-10-01), Blaschuk et al.
patent: WO 88/00837 (1988-02-01), None
Prasad JA et al (Can. J. Physiol. Pharmocol. Feb. 1995;73(2):209-14).
Bowie et al. Science, 247:1306-1310, 1990.
Lazar et al. Molecular and Cellular Biology 8:1247-1252, 1988.
Burgess et al., J of Cell Bio. 111:2129-2138, 1990.
Arap et al., “Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model,”Science, 279:377-380, 1998.
Barry et al., “Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries,”Nature Med., 2:299-305, 1996.
Cherny et al., “Site-directed mutagenesis of the arginine—glycine-aspartic acid in vitronectin abolishes cell adhesion,”J. Biol. Chem., 268:9725-9729, 1993.
Clayman, “In vivo molecular therapy with p53 Adenovirus for Microscopic Residual Head and Neck Squamous Carcinoma,”Can. Res., 55:1-6, 1995.
D'Souza et al., “Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif,”Trends Biochem. Sci., 16(7):246-250, 1991.
Pasqalini et al., “Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis,”Cancer Res., 60(3):722-727, 2000.
Pasqualini and Ruoslahti, “Organ targeting in vivo using phage display peptide libraries,”Nature, 380:364-366, 1996.
Wu et al., “Receptor-mediated in vitro gene transformation by a soluble DNA carrier system,”J. Biol. Chem., 262:4429-4432, 1987.
Behr et al., “Radiolabeled peptides for targeting Cholecystokinin-B/Gastrin receptor-expressing tumors,”J. Nucl. Med., 40:1029-1044, 1999.
Carpenter and Minchin, “Targeting of a cholecystokinin-DNA complex to pancreatic cells in vitro and in vivo,”Gene Therapy, 5:848-854, 1998.
Hong and Clayman, “Isolation of a peptide for targeted drug delivery into human head and neck solid tumors,”Cancer Res., 60:6551-6556, 2000.
Koivunen et al., “Identification of receptor ligands with phage display peptide libraries,”J. Nucl. Med., 40:883-888, 1999.
Sauk et al., “Binding motifs of CBP2 a potential cell surface target for carcinoma cells,”J. Cell. Biochem., 78:251-263, 2000.
Schatzlein et al., “Targeting of tumor cells with peptides identified by phage display,”Proceedings of the American Association for cancer Research91stAnnual Meeting, 41:103, Abstract # 655, 2000.
Wagner, “Receptor-mediated delivery of plasmid DNA,”Biogenic Amines, 14(5):519-536, 1998.
Clayman Gary
Hong Frank D.
Board of Regents , The University of Texas System
Fulbright & Jaworski
Nickol G.
Yaen C
LandOfFree
Isolation of a cell-specific internalizing peptide that... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolation of a cell-specific internalizing peptide that..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolation of a cell-specific internalizing peptide that... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3383042